Increases in the nuclear regulators glycogen synthase kinase-3 beta (GSK3β) and Bach1 have been associated with limiting NRF2 activation [91,92], and nuclear GSK3β is increased in advanced T2DM, potentially inhibiting NRF2 activation [52]. This evidence concerns the gene GSK3B and type 2 diabetes mellitus.